- Record: found
- Abstract: not found
- Article: not found
Phase 1 study: safety and tolerability of increasing doses of CB-839, an orally-administered small molecule inhibitor of glutaminase, in acute leukemia
Konopleva, M.Y. Konopleva, I.W. Flinn, E.S. Wang, C.D. DiNardo, M.K Bennett, C.J. Molineaux, M Konopleva, IW Flinn, ES Wang, CD DiNardo, MK Bennett, C Molineaux, MH Le, MB Maris, O Frankfurt
2015
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.